Dissemination plans {31a}
All essential results of the clinical trial will be submitted to the responsible higher federal authority and the ethics committee within 1 year after the end of the clinical trial. In addition, the results and, if necessary, other necessary information will be published in the European database. Links to publications will be provided to the trial registry. The trial results will be reported on the trial webpage and to the institutional review boards, the funding agency and the consortium partners of the Horizon2020 project. The full trial database and analysis dataset will be reported to the competent regulatory authorities and, as far as possible, made available to the Open Research Data Pilot. All results will be published open access. Wherever possible, the ‘gold’ open access route will be preferred. If the gold route is not feasible, the green route with self-archiving will be selected.A dedicated work package within the TTVguideTX project will cover the dissemination and communication of the study results according to a dedicated roadmap targeting a diverse group of stakeholders by target-specific channels.